Genzyme diagnostic, biomanufacturing news

Carl Icahn submitted a proxy statement to the SEC outlining which four of the Genzyme board members - including Chairman, President and CEO Henri Termeer - he hopes to replace with his own slate. Others he seeks to oust are independent directors Charles Cooney, a professor of chemical and biochemical engineering at the Massachusetts Institute of Technology; Connie Mack III, a former U.S. Senator; and Richard Syron, a professor of finance at Boston College. In February, Icahn announced his intent to nominate himself, Steven Burakoff, Alexander Denner and Richard Mulligan to the board. Genzyme's annual meeting is scheduled for June 16. ...